banner cat dog
BLACK FRIDAY SALE - NOV 26 - DEC 5SAVE 25% + WIN DAILY PRIZES
COUPON CODE

Loading...

home
Order Tests for Dogs
DNA Tests
Cerebellar Cortical Degeneration (Hungarian Vizsla Type)

Description

Genetic basis of CCD in Hungarian Vizslas - is caused by a splice donor site mutation (c.2653+1G>A) in the SNX14 gene (Sorting Nexin 14). The SNX14 gene is involved in maintaining normal neuronal excitability and synaptic transmission. This mutation leads to degeneration and loss of Purkinje cells in the cerebellum, with secondary degeneration of granular and molecular cell layers, resulting in cerebellar atrophy. The disease is inherited in an autosomal recessive manner: affected dogs have two copies of the mutation (P/P), carriers one copy (N/P) and are asymptomatic, and clear dogs have no copies (N/N).

Pathophysiology -
The mutation causes primary degeneration of Purkinje neurons in the cerebellar cortex. This leads to progressive loss of motor coordination due to dysfunction in cerebellar circuitry. Secondary effects include thinning of other cerebellar layers and overall cerebellar atrophy.

Clinical Signs and Progression -
Progressive cerebellar ataxia (lack of coordination), Intention tremors and head tremors, Truncal sway and hypermetric/dysmetric gait, Insufficient menace response (loss of protective reflex), Positional horizontal nystagmus (involuntary eye movement), The progression is relatively fast after onset, severely impairing coordination and balance.

Summary - 
Cerebellar Cortical Degeneration in Hungarian Vizslas is a fatal autosomal recessive neurodegenerative disorder caused by a splice site mutation in the SNX14 gene. It presents with progressive cerebellar ataxia starting around 3 months of age due to Purkinje neuron loss and cerebellar atrophy. Genetic testing facilitates early diagnosis and supports breeding programs to reduce disease prevalence and prevent affected puppies.

Recommended Breeding

Diseases

Cerebellar Cortical Degeneration (Hungarian Vizsla Type)

$ 50.00

1

Associated Breed(s):

Click here to view Associated Breeds

Labels:

Pathogenic (P)

A healthcare provider can use molecular testing information in clinical decision‑making for breeding programs and/or screening.

Category:

Nervous system / Neurologic - Associated with the brain, spinal cord and nerves

Severity:

Moderate-Severe. This is a disease with significant welfare impact on the affected animal, in terms of clinical signs and generally reduced life expectancy.

Gene:

SNX14

Variant Detected:

c.2653+1G>A

Mode of Inheritance:

Autosomal Recessive

OMIA Reference:

Click to View Full OMIA Reference